This program project addresses the problem of childhood tumors at both a clinical and basic science level. Seven projects are included: Project 1 investigates the cellular basis of graft versus host disease and post-trensplantation immunoincompetence as well as the clinical use of monoclonal antibody to prevent graft versus host disease and reduce the incidence of leukemic relapse. Project 2 studies the regulation of the cytolytic T lymphocyte response to alloantigens, tumor antigens, and viral-induced antigens. Project 3 defines the cell-cell interactions which regulate erythropoiesis, with particular reference to the T cell regulatory system. The effect of inducers of differentiaton upon the cell cycle kinetics, globin chain program and erythropoietin response of human peripheral blood erythroid progenitor cells will be examined. Techniques to enrich these erythroid progenitor cells will be developed. Project 4 studies the pharmacology of chemotherapeutic agents which interfere with DNA synthesis. The role of the de novo and salvage pathways for nucleic acid synthesis will be examined in relationship to methotrexate action. The incorporation of Ara-C and Ara-A into DNA will be examined as the molecular basis for the action of these agents. Project 5 studies the selective synthesis of cellular proteins as a rapid response of BALB/c-3T3 cells to the addition of growth factors; variants of BALB/c-3T3 cells which don't require these growth factors, will be isolated and shown to constitutively synthesize these proteins. Project 6 studies the replicative cycle of hr-t mutants of polyoma virus, which display coordinate defects in virus growth and cell transformation; the block in hr-t replication, which appears to be a defect in the assembly or maturation of infectious particles, will be defined. Project 7 studies transmembrane signalling using a model system, the galactose-terminal glycoprotein receptor of rat hepatocytes; the receptor protein will be identified and the receptor-mediated translocation of the ligand will be characterized.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA018662-10
Application #
3092785
Study Section
(SRC)
Project Start
1978-09-01
Project End
1987-02-28
Budget Start
1985-03-01
Budget End
1986-02-28
Support Year
10
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
van Dijken, P J; Ghayur, T; Mauch, P et al. (1990) Evidence that anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation 49:882-6
Ferrara, J L; Mauch, P; Van Dijken, P J et al. (1990) Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients. Transplantation 49:134-8
Blatter, D D; Crawford, J M; Ferrara, J L (1990) Nuclear magnetic resonance of hepatic graft-versus-host disease in mice. Transplantation 50:1011-8
Ferrara, J L; Guillen, F J; van Dijken, P J et al. (1989) Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation 47:50-4
Bierer, B E; Burakoff, S J; Smith, B R (1989) A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation. Blood 73:1359-66
Ferrara, J L; Michaelson, J; Burakoff, S J et al. (1988) Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients. Transplantation 45:948-52
Bierer, B E; Emerson, S G; Antin, J et al. (1988) Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation 46:835-9
Bierer, B E; Nishimura, Y; Burakoff, S J et al. (1988) Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5. J Clin Invest 81:1390-7
Antin, J H; Ault, K A; Rappeport, J M et al. (1987) B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes. J Clin Invest 80:325-32
Ferrara, J L; Mauch, P; McIntyre, J et al. (1987) Engraftment following T-cell-depleted bone marrow transplantation. II. Stability of mixed chimerism in semiallogeneic recipients after total-body irradiation. Transplantation 44:495-9

Showing the most recent 10 out of 28 publications